Daiwa Securities Group Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$37
-30.2%
38,7350.0%0.00%
Q2 2023$53
-13.1%
38,7350.0%0.00%
Q1 2023$61
-74.6%
38,7350.0%0.00%
-100.0%
Q4 2022$240
-99.9%
38,735
-39.9%
0.00%
-50.0%
Q3 2022$432,000
+5.6%
64,4350.0%0.00%
+33.3%
Q2 2022$409,000
-1.9%
64,435
-28.4%
0.00%0.0%
Q1 2022$417,000
+19.1%
90,052
+28.6%
0.00%
+50.0%
Q4 2021$350,000
+34900.0%
70,052
+134615.4%
0.00%
Q3 2021$1,0000.0%520.0%0.00%
Q2 2021$1,0000.0%520.0%0.00%
Q1 2021$1,0000.0%520.0%0.00%
Q4 2020$1,000
-83.3%
52
-66.2%
0.00%
Q3 2020$6,000
+20.0%
1540.0%0.00%
Q2 2020$5,0000.0%1540.0%0.00%
Q1 2020$5,000
-44.4%
1540.0%0.00%
Q4 2019$9,000
+50.0%
154
-9.9%
0.00%
Q3 2019$6,000
-25.0%
1710.0%0.00%
Q2 2019$8,000
+14.3%
1710.0%0.00%
Q1 2019$7,0000.0%171
+17.9%
0.00%
Q4 2018$7,000
+16.7%
1450.0%0.00%
Q3 2018$6,0000.0%1450.0%0.00%
Q2 2018$6,000
-40.0%
1450.0%0.00%
Q1 2018$10,0001450.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders